NTES-S
09999
JD HEALTH
06618
TRIP.COM-S
09961
JD-SW
09618
BILIBILI-W
09626
(Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Cash flow from operating activities | ||||||||||
Earning before tax | ---- | 357.67%767.65M | ---- | -211.87%-928.33M | ---- | -73.34%167.73M | ---- | 273.36%829.85M | ---- | 51.64%629.04M |
Profit adjustment | ||||||||||
Interest (income) - adjustment | ---- | 24.16%-18.6M | ---- | 48.02%-28.14M | ---- | 15.45%-24.52M | ---- | 4.35%-54.14M | ---- | -3.56%-29M |
Dividend (income)- adjustment | ---- | ---- | ---- | -412.64%-36.43M | ---- | ---- | ---- | 83.87%-7.11M | ---- | 89.03%-4.84M |
Attributable subsidiary (profit) loss | ---- | -66.52%77.77M | ---- | 354.95%447.95M | ---- | 322.41%232.29M | ---- | -18.11%98.46M | ---- | 679.76%54.99M |
Impairment and provisions: | ---- | -371.10%-11.45M | ---- | 137.48%145.02M | ---- | -54.37%4.22M | ---- | -81.21%61.07M | ---- | -13.05%9.25M |
-Impairment of property, plant and equipment (reversal) | ---- | ---- | ---- | --44.52M | ---- | ---- | ---- | ---- | ---- | ---- |
-Impairment of goodwill | ---- | ---- | ---- | --68.16M | ---- | ---- | ---- | ---- | ---- | ---- |
-Other impairments and provisions | ---- | -371.10%-11.45M | ---- | -47.03%32.35M | ---- | -54.37%4.22M | ---- | -81.21%61.07M | ---- | -13.05%9.25M |
Revaluation surplus: | ---- | 426.98%87.68M | ---- | -117.34%-17.64M | ---- | -286.87%-26.81M | ---- | 259.19%101.7M | ---- | 1,174.83%14.35M |
-Derivative financial instruments fair value (increase) | ---- | -507.14%-8.61M | ---- | -99.68%86K | ---- | -3.65%2.11M | ---- | 542.65%26.87M | ---- | -61.76%2.19M |
-Other fair value changes | ---- | 432.84%96.28M | ---- | -123.69%-17.72M | ---- | -337.99%-28.93M | ---- | 209.94%74.83M | ---- | 271.85%12.16M |
Asset sale loss (gain): | ---- | -3,165.06%-272.8M | ---- | 50.69%-6.6M | ---- | -280.98%-8.36M | ---- | -1,940.70%-13.39M | ---- | 65.38%-2.19M |
-Loss (gain) from sale of subsidiary company | ---- | -3,644.23%-272.02M | ---- | 66.63%-7.27M | ---- | ---7.27M | ---- | ---21.77M | ---- | ---- |
-Loss (gain) on sale of property, machinery and equipment | ---- | 320.83%583K | ---- | -39.20%1.68M | ---- | -525.81%-264K | ---- | -45.94%2.76M | ---- | 103.74%62K |
-Loss (gain) from selling other assets | ---- | -64.77%-1.36M | ---- | -118.03%-1.01M | ---- | 63.37%-826K | ---- | 197.62%5.62M | ---- | 51.79%-2.26M |
Depreciation and amortization: | ---- | 0.80%174.38M | ---- | 21.10%377.85M | ---- | 13.46%172.98M | ---- | 1.70%312.01M | ---- | 0.58%152.47M |
-Amortization of intangible assets | ---- | 0.01%27.65M | ---- | 5.25%56.09M | ---- | 8.18%27.65M | ---- | 3.45%53.3M | ---- | -1.57%25.56M |
Financial expense | ---- | -33.06%84.5M | ---- | -7.14%228.09M | ---- | 2.61%126.23M | ---- | 16.92%245.63M | ---- | 13.51%123.01M |
Exchange Loss (gain) | ---- | 109.57%12.13M | ---- | 53.92%-85.87M | ---- | -23.29%-126.85M | ---- | -190.87%-186.33M | ---- | -574.72%-102.89M |
Operating profit before the change of operating capital | ---- | 74.35%901.27M | ---- | -93.09%95.89M | ---- | -38.77%516.91M | ---- | 13.36%1.39B | ---- | 36.65%844.19M |
Change of operating capital | ||||||||||
Inventory (increase) decrease | ---- | 147.77%631.87M | ---- | 108.88%189.8M | ---- | -26.78%-1.32B | ---- | -38.79%-2.14B | ---- | -134.91%-1.04B |
Accounts receivable (increase)decrease | ---- | -116.11%-47.29M | ---- | 338.66%316.35M | ---- | 208.50%293.5M | ---- | -247.34%-132.56M | ---- | -561.10%-270.5M |
Accounts payable increase (decrease) | ---- | 716.73%42.46M | ---- | -219.88%-137.65M | ---- | -109.35%-6.89M | ---- | -33.30%114.83M | ---- | -25.83%73.64M |
prepayments (increase)decrease | ---- | -761.12%-278.26M | ---- | -13.78%60.11M | ---- | -120.73%-32.31M | ---- | 216.80%69.71M | ---- | 2,795.59%155.91M |
Special items for working capital changes | ---- | 51.51%66.72M | ---- | -209.59%-67.17M | ---- | -47.22%44.03M | ---- | -48.87%61.29M | ---- | -30.18%83.44M |
Cash from business operations | ---- | 359.45%1.32B | ---- | 171.98%457.33M | ---- | -223.95%-507.53M | ---- | -814.36%-635.34M | ---- | -145.32%-156.67M |
Other taxs | ---- | 12.98%-37.11M | ---- | 51.62%-62.14M | ---- | 52.27%-42.64M | ---- | -26.96%-128.44M | ---- | -5.47%-89.35M |
Interest received - operating | ---- | 104.51%15.18M | ---- | -57.68%3.03M | ---- | 40.61%7.42M | ---- | 28.02%7.16M | ---- | 14.56%5.28M |
Adjustment items of business operations | 865.91%1.79B | ---- | 511.47%880.45M | ---- | 67.47%-233.99M | ---- | -15,418.93%-213.98M | ---- | -686.10%-719.28M | ---- |
Net cash from operations | 865.91%1.79B | 338.57%1.29B | 511.47%880.45M | 152.63%398.22M | 67.47%-233.99M | -125.45%-542.75M | -15,418.93%-213.98M | -11,313.70%-756.61M | -686.10%-719.28M | -190.63%-240.74M |
Cash flow from investment activities | ||||||||||
Interest received - investment | ---- | 376.67%4.72M | ---- | -35.43%28.14M | ---- | -94.84%990K | ---- | -20.12%43.59M | ---- | -34.57%19.19M |
Dividend received - investment | 892.18%320.92M | -76.23%3.72M | -32.71%13.37M | 157.67%53.49M | -65.58%32.34M | -24.66%15.64M | 310.77%19.86M | -67.69%20.76M | -84.01%93.98M | -54.57%20.76M |
Decrease in deposits (increase) | ---- | -36.67%-41M | ---- | -4.88%665.87M | ---- | -109.09%-30M | ---- | 1,078.84%700M | ---- | 319.51%330M |
Sale of fixed assets | 20.25%2.79M | 486.70%2.73M | -78.81%21.38K | -7.66%2.34M | 1,430.35%2.32M | 210.67%466K | 12.01%100.9K | 47.32%2.53M | -10.87%151.84K | 7,400.00%150K |
Purchase of fixed assets | 48.96%-140.27M | 65.60%-45.22M | -7.42%-60.42M | -106.09%-437.43M | -69.06%-274.84M | -32.56%-131.45M | -57.75%-56.25M | -21.13%-212.26M | -12.30%-162.56M | -24.80%-99.16M |
Purchase of intangible assets | ---- | -35.91%-5.92M | ---- | 26.76%-7.45M | ---- | -20.09%-4.35M | ---- | 45.42%-10.17M | ---- | 54.92%-3.62M |
Sale of subsidiaries | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --6.4M | ---- | ---- |
Recovery of cash from investments | -23.14%1.15B | -24.45%1.08B | -64.11%423.55M | -61.59%1.59B | -39.48%1.49B | 2.77%1.43B | 89.85%1.18B | 28.29%4.15B | 1.77%2.47B | -33.30%1.4B |
Cash on investment | -111.53%-1.44B | -139.92%-842.61M | 37.90%-220M | 84.89%-677.26M | 75.16%-683.04M | 80.25%-351.21M | 48.00%-354.28M | -89.13%-4.48B | -82.81%-2.75B | -69.91%-1.78B |
Other items in the investment business | -115.35%-113.73M | ---- | -514.68%-25.82M | ---- | 111.40%740.67M | ---- | 158.62%6.23M | --31.54M | 206.45%350.36M | ---- |
Net cash from investment operations | -117.24%-226.22M | -82.87%160.06M | -83.57%130.69M | 388.94%1.22B | 55,654.49%1.31B | 908.77%934.48M | 1,003.94%795.65M | -65.30%249.84M | -99.77%2.35M | -113.09%-115.54M |
Net cash before financing | 45.21%1.57B | 271.41%1.45B | 73.83%1.01B | 419.63%1.62B | 250.41%1.08B | 209.95%391.73M | 750.64%581.67M | -171.05%-506.77M | -161.80%-716.93M | -131.02%-356.29M |
Cash flow from financing activities | ||||||||||
New borrowing | -35.87%2.28B | -42.52%1.66B | -45.50%826.83M | -24.37%5.11B | -27.83%3.56B | -20.52%2.88B | 6.36%1.52B | 82.90%6.76B | 70.52%4.93B | 151.76%3.63B |
Refund | 14.48%-3.5B | 17.00%-2.6B | 11.08%-1.43B | 4.33%-5.85B | -12.95%-4.1B | -43.60%-3.13B | -120.25%-1.61B | -63.86%-6.11B | -23.39%-3.63B | -15.75%-2.18B |
Interest paid - financing | ---- | 36.95%-93.86M | ---- | 0.80%-249.83M | ---- | 3.87%-148.87M | ---- | -28.13%-251.84M | ---- | 3.59%-154.87M |
Dividends paid - financing | 46.83%-133.24M | ---- | 39.14%-61.11M | -657.84%-176.21M | -19.55%-250.6M | ---- | -53.25%-100.42M | 89.44%-23.25M | 45.14%-209.61M | ---- |
Absorb investment income | --192.34K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Other items of the financing business | -91.74%9.8M | -76.05%25M | -104.30%-3.24M | ---7.2M | 197.58%118.58M | 298.91%104.37M | 706.93%75.45M | ---- | -236.07%-121.52M | ---52.47M |
Net cash from financing operations | -100.26%-1.35B | -235.29%-1.03B | -461.03%-670.83M | -467.20%-1.21B | -169.27%-672.1M | -124.98%-306.84M | -119.39%-119.57M | 165.77%329.57M | 307.43%970.22M | 303.28%1.23B |
Effect of rate | -68.98%9.87M | -67.15%10.99M | 108.48%2.43M | 110.18%36.33M | 200.62%31.82M | 691.02%33.46M | -194.21%-28.66M | 127.51%17.28M | 138.64%10.59M | 114.43%4.23M |
Other items affecting net cash | ---- | ---- | ---- | ---- | ---- | --1K | ---- | ---- | ---- | ---- |
Net Cash | -45.86%219.96M | 401.93%426.08M | -26.36%340.31M | 331.15%409.61M | 60.39%406.25M | -90.26%84.89M | -12.38%462.1M | -183.50%-177.21M | -63.41%253.29M | 60.18%871.99M |
Begining period cash | 33.79%1.77B | 33.79%1.77B | 33.79%1.77B | -10.81%1.32B | -10.81%1.32B | -10.81%1.32B | -10.81%1.32B | 11.23%1.48B | 11.23%1.48B | 11.23%1.48B |
Cash at the end | 13.52%2B | 53.17%2.2B | 20.26%2.11B | 33.79%1.77B | 0.82%1.76B | -38.96%1.44B | -12.22%1.75B | -10.81%1.32B | -12.61%1.74B | 27.67%2.36B |
Cash balance analysis | ||||||||||
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | CAS (2007) | IAS | CAS (2007) | IAS | CAS (2007) | IAS | CAS (2007) | IAS | CAS (2007) | IAS |
Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- | -- |
Auditor | -- | -- | -- | Ernst & Young Huaming Certified Public Accountants (Special General Partnership) | -- | -- | -- | Ernst & Young Huaming Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.